Vesencumab
Vesencumab Basic information
- Product Name:
- Vesencumab
- Synonyms:
-
- Vesencumab
- Research Grade Vesencumab (DHA30101)
- Research Grade Vesencumab
- Vesencumab (anti-NRP1)
- CAS:
- 1205533-60-3
- MW:
- 0
- Mol File:
- Mol File
Vesencumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
Vesencumab Usage And Synthesis
Uses
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer[1][2].
in vivo
Vesencumab (10 mg/kg, ip, twice a week for 7 weeks) exhibits antitumor effect in mouse SUM159 orthotopic xenograft models[3].
| Animal Model: | Mouse SUM159 orthotopic xenograft models[3] |
| Dosage: | 10 mg/kg |
| Administration: | ip, twice a week for 7 weeks |
| Result: | Inhibited tumor volume and weight. |
References
[1] Jonathan Stephens, et al. Rare disease landscape: will the blockbuster model be replaced? Expert Opinion on Orphan Drugs. Volume 2, 2014 - Issue 8.
[2] Zhang J, et al. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications. Cells. 2022 Oct 25;11(21):3362. DOI:10.3390/cells11213362
VesencumabSupplier
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 15817493340
- 981810490@qq.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 4008200310
- marketing@tsbiochem.com